White House halts research into ‘super strains’ of infectious diseases

Oct 21, 2014

Image credit: CDC

By Elizabeth Lopatto

The White House has halted research examining how diseases like influenza, MERS, and SARS can be more easily transmitted among animals, citing safety concerns. The US will not fund any new research and is encouraging those with existing research to pause their experiments.

There were apparently biosafety “incidents” at federally-funded research centers. As a result, the White House Office of Science and Technology Policy, along with the Department of Health and Human Services, is launching “a deliberative process” to assess risks associated with this type of research.

In August, a CDC researcher contaminated samples while rushing to a meeting. And in June, the CDC left anthrax samples unlocked and used expired disinfectant on them. It’s not clear from the White House statement if these were the incidents being referred to. A call to Becky Fried, a spokeswoman for the White House Office of Science and Technology Policy wasn’t immediately returned.

Called “gain of function” research, these studies increase infectious agents’ ability to cause disease, or make it easier for them to spread. Right now, these types of studies are ongoing in influenza, Middle Eastern respiratory syndrome, and sudden acute respiratory syndrome. The White House is particularly concerned with research expected to create versions of those pathogens that increase airborne transmission.


 

Read the full article by clicking the name of the source located below.

One comment on “White House halts research into ‘super strains’ of infectious diseases”

  • If research with dangerous pathogens is to be carried out, it needs to be properly funded and rigorously properly managed.

    It is note-worthy that a UK Foot and Mouth outbreak in cattle was caused by mismanaged waste from a veterinary a lab!



    Report abuse

Leave a Reply

View our comment policy.